Opicapone as Adjunct to Levodopa Therapy in Patients With Parkinson Disease and Motor Fluctuations-Reference-Cited by-同舟云学术

Opicapone as Adjunct to Levodopa Therapy in Patients With Parkinson Disease and Motor Fluctuations

Published:2017-02-01 Issue:2 Volume:74 Page:197
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Lees Andrew J.¹,Ferreira Joaquim²,Rascol Olivier³,Poewe Werner⁴,Rocha José-Francisco⁵,McCrory Michelle⁶,Soares-da-Silva Patricio⁷,

Affiliation:

1. Reta Lila Weston Institute, University College London, London, England

2. Centro de Estudos Egas Moniz, Hospital de Santa Maria, Lisbon, Portugal

3. Department of Clinical Pharmacology, Institut National de la Santé et de la Recherche Medicale (INSERM) and University Hospital of Toulouse, Toulouse, France4Department of Neurosciences, INSERM and University Hospital of Toulouse, Toulouse, France

4. Department of Neurology, Innsbruck Medical University, Innsbruck, Austria

5. Department of Research and Development, BIAL–Portela & Ca SA, Sao Mamede do Coronado, Portugal

6. Quintiles, Dublin, Ireland

7. Department of Research and Development, BIAL–Portela & Ca SA, Sao Mamede do Coronado, Portugal8Department of Pharmacology and Therapeutics, University Porto, Porto, Portugal

Publisher

American Medical Association (AMA)

Subject

Neurology (clinical)

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Addressing the Ethnicity Gap in Catechol O-Methyl Transferase Inhibitor Trials in Parkinson’s Disease: A Review of Available Global Data;Journal of Personalized Medicine;2024-09-03

2. Pharmacotherapy of motor symptoms in early and mid-stage Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology;Journal of Neurology;2024-08-29

3. Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson’s disease: pooled analysis of patient level data from two randomized open-label studies;Journal of Neurology;2024-08-21

4. Factors associated with a placebo effect in Parkinson’s disease in clinical trials: a meta-analysis;Journal of Neurology;2024-07-02

5. Disease Stage and Motor Fluctuation Duration Predict Drug Tolerability: A Real-Life, Prospective Italian Multicenter Study on the Use of Opicapone in Parkinson’s Disease;Drugs - Real World Outcomes;2024-07-02